RhumbLine Advisers’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Buy |
3,005
+1,701
| +130% | +$11.8K | ﹤0.01% | 3788 |
|
|
2025
Q1 | $11.1K | Buy |
1,304
+147
| +13% | +$1.25K | ﹤0.01% | 3821 |
|
|
2024
Q4 | $16.2K | Buy |
1,157
+57
| +5% | +$798 | ﹤0.01% | 3822 |
|
|
2024
Q3 | $24.9K | Buy |
1,100
+73
| +7% | +$1.65K | ﹤0.01% | 3793 |
|
|
2024
Q2 | $20.8K | Buy |
1,027
+388
| +61% | +$7.85K | ﹤0.01% | 3866 |
|
|
2024
Q1 | $15.9K | Buy |
639
+229
| +56% | +$5.7K | ﹤0.01% | 3795 |
|
|
2023
Q4 | $7.41K | Hold |
410
| – | – | ﹤0.01% | 3914 |
|
|
2023
Q3 | $8.23K | Buy |
410
+30
| +8% | +$602 | ﹤0.01% | 3902 |
|
|
2023
Q2 | $9.7K | Buy |
+380
| New | +$9.7K | ﹤0.01% | 3962 |
|